UTI - Urinary Tract InfectionCOLLECT-UTINCT07766278
Urine Collection and Novel UTI Biomarkers in Children and Older Adults
An observational study of UTI - Urinary Tract Infection, run by Queen's University, Belfast at 1 site in United Kingdom.
Trial summary
Suspected urinary tract infection (UTI) is a common driver of antibiotic prescribing and hospital admission, yet accurate diagnosis remains challenging. Young children and older adults often present without localising urinary symptoms, and current urine tests perform poorly in these groups. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- UTI - Urinary Tract Infection
- How many people
- 230 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 27 Aug 2026to 17 Aug 2029
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Children under 5 years olds and older adults aged 65 years and over, attending the Royal Victoria Hospital Emergency Departments who are undergoing routine clinical investigation for suspected urinary tract infection.
Who may be able to join
- Children:
- Children under 5 years of age who are not toilet trained.
- Urine dipstick positive for nitrates or leukocytes (including trace).
- Residual urine sample remaining following completion of all routine clinical urine testing.
- Older Adults:
- Adults aged 65 years and over.
- Urine dipstick positive for nitrates or leukocytes (including trace).
- Residual urine sample remaining following completion of all routine clinical urine testing.
Who cannot join
- Consent declined.
- Inability to obtain informed consent.
- Antibiotic treatment within the previous 48 hours for acute infection.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom1 site, 1 recruiting
- Recruiting
Queen's University Belfast
Belfast, Northern Ireland, BT9 7BL
Clare Mills, PhD, 028 9097 6466, clare.mills@qub.ac.uk
About this study
Official title: Urine COLLECTion and Novel UTI Biomarkers in Children and Older Adults (COLLECT - UTI)
Suspected urinary tract infection (UTI) is a common driver of antibiotic prescribing and hospital admission, yet accurate diagnosis remains challenging. Young children and older adults often present without localising urinary symptoms, and current urine tests perform poorly in these groups. In non-toilet-trained children, non-invasive urine collection methods are associated with high contamination rates. In older adults, asymptomatic bacteriuria (ASB) is common and complicates interpretation of urine culture results. As UTIs are a leading cause of sepsis in both groups, this diagnostic uncertainty contributes to overdiagnosis and overtreatment. COLLECT-UTI aims to improve UTI diagnostics by evaluating novel urinary host and bacterial markers to distinguish true UTI from contaminated samples in children and from ASB in older adults.
The COLLECT-UTI study is a prospective observational study of children under 5 years of age and adults aged 65 years and over undergoing testing for suspected urinary tract infection (UTI). The study will recruit approximately 230 participants in total. Clinical features, laboratory results and 14-day outcomes will be recorded on an electronic case report form (CRF) and REDCap database. Residual urine samples collected during routine clinical care will be used to investigate novel urinary host biomarkers and bacterial markers to improve the diagnosis of UTI.
Read the detailed description
Background:
Urinary tract infection (UTI) is one of the most common bacterial infections requiring medical assessment in young children and older adults. Accurate diagnosis is particularly challenging at the extremes of age, where patients frequently present with non-specific symptoms and current urine diagnostic tests perform poorly. In young children, contamination of urine samples collected using non-invasive methods often results in false-positive urine cultures, while in older adults the high prevalence of asymptomatic bacteriuria (ASB) makes it difficult to distinguish bacterial colonisation from true infection. These diagnostic limitations contribute to unnecessary antibiotic prescribing, avoidable hospital admissions and increased antimicrobial resistance. This study aims to evaluate novel urinary host and bacterial biomarkers to improve the diagnosis of UTI by distinguishing true infection from contamination in children and from ASB in older adults.
Objectives:
Primary Objectives:
- Determine the diagnostic accuracy (sensitivity, specificity and AUC) of urinary host biomarkers for diagnosing paediatric UTI across different urine collection methods.
- To characterise the molecular features of urine samples from children with different microbiological classifications of urinary tract infection.
- To characterise the molecular features of urine samples from older adults with symptomatic urinary tract infection and asymptomatic bacteriuria.
Study Design:
A prospective observational study conducted in the Emergency Departments of the Royal Belfast Hospital for Sick Children and the Royal Victoria Hospital. The paediatric component comprises a diagnostic accuracy cohort study with a nested case-control transcriptomic study, while the adult component is a case-control study comparing symptomatic UTI with asymptomatic bacteriuria.
Study Population:
Children under 5 years of age who are not toilet trained and have urine sent for culture for suspected UTI, and adults aged 65 years and over undergoing urine culture for suspected UTI in the Emergency Department. Participants must have sufficient residual urine remaining following routine clinical testing. Exclusion criteria include inability to obtain consent and antibiotic treatment within the preceding 48 hours.
Setting:
Royal Belfast Hospital for Sick Children Emergency Department and Royal Victoria Hospital Emergency Department, Belfast.
Screening:
Potential participants will be identified by the clinical care team. Following informed consent, clinical information and laboratory results will be recorded on a case report form (CRF), with clinical outcomes reviewed 14 days after presentation.
Procedures:
Residual urine samples collected during routine clinical care will be retained following consent. Where available, residual plasma from routine blood sampling may also be stored. No additional urine collection or phlebotomy will be performed for research purposes. Samples will be pseudonymised, transported to Queen's University Belfast for storage and analysis, and used for urinary biomarker measurement, bacterial RNA sequencing and bacterial isolate banking.
Reference Standards:
In children, UTI will be defined using predefined urine culture thresholds according to urine collection method. Samples selected for bacterial RNA sequencing may include urine from children with confirmed UTI, contaminated urine samples and, where available, healthy control samples. In older adults, symptomatic UTI and asymptomatic bacteriuria will be classified using documented urinary symptoms together with urine culture results according to established guideline criteria.
- Conditions
- UTI - Urinary Tract Infection
- Keywords
- Urinary Tract Infection, Paediatrics, Older Adults, Biomarkers, Urine
- Medical subject headings
- Urinary Tract Infections
What is being measured
The primary outcome is the main question the study is designed to answer.
Sensitivity, specificity and area under the receiver operating characteristic curve (AUC) of urinary host biomarkers for paediatric UTI
The diagnostic performance of urinary host biomarkers for paediatric UTI will be evaluated against the reference standard urine culture. Sensitivity, specificity and area under the receiver operating characteristic curve (AUC) will be calculated, with diagnostic performance also compared across urine collection methods.
Measured: 14 days from attendance
Molecular characterisation of paediatric urine samples
Molecular analyses will be performed to identify biological signatures associated with different urine sample classifications, including confirmed UTI, contaminated samples and, where available, healthy controls.
Measured: 14 days from attendance
Molecular characterisation of urine samples from older adults
Molecular analyses will be performed to identify biological signatures associated with symptomatic UTI and asymptomatic bacteriuria.
Measured: 14 days from attendance
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2026
- Study start27 Aug 2026
- Primary completion17 Aug 2028 (estimated)
- Study completion17 Aug 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for UTI - Urinary Tract InfectionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 230 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Queen's University, Belfast
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Thomas Waterfield, Queen's University, Belfast
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07766278
- Sponsor's protocol ID
- NIB26-0004
- Acronym
- COLLECT-UTI
- Status last verified
- Oct 2026
- First submitted
- 7 Aug 2026
- Last updated
- 15 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No